Meningiomas and neurofibromatosis

Journal of Neuro-Oncology

Volumn 99, Issue 3, 2010, Pages 341-347

  Goutagny, Stéphane ^a,b,c   Kalamarides, Michel ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c BEAUJON HOSPITAL   (France)

Author keywords

Meningioangiomatosis; Multiple meningiomas; NF1; NF2; Schwannomatosis

Indexed keywords

BEVACIZUMAB; NEUROFIBROMATOSIS TYPE 2 PROTEIN; TUMOR PROTEIN; UNCLASSIFIED DRUG;

BRAIN DISEASE; CLINICAL ASSESSMENT; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; DRUG EFFICACY; GAMMA KNIFE RADIOSURGERY; HIGH RISK PATIENT; HUMAN; MENINGIOANGIOMATOSIS; MENINGIOMA; MENINX; MORTALITY; MOSAICISM; NEURILEMOMA; NEUROFIBROMATOSIS; NEUROIMAGING; NEUROPATHOLOGY; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; REVIEW; SKULL BASE; SOMATIC MUTATION; STEREOTACTIC RADIOSURGERY; TUMOR LOCALIZATION;

DIAGNOSIS, DIFFERENTIAL; HUMANS; MENINGEAL NEOPLASMS; MENINGIOMA; NEUROFIBROMATOSES; PROGNOSIS;

EID: 77957564914     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-010-0339-x     Document Type: Review

References (51)

1. DG Evans E Howard C Giblin T Clancy H Spencer SM Huson F Lalloo 2010 Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service Am J Med Genet A 152A 327 332 1:STN:280:DC%2BC3c%2FmslentQ%3D%3D 10.1002/ajmg.a.33139 20082463
2. DG Evans SM Huson D Donnai W Neary V Blair V Newton R Harris 1992 A clinical study of type 2 neurofibromatosis Q J Med 84 603 618 1:STN:280:DyaK3s7jsVSjug%3D%3D 1484939
3. DM Parry R Eldridge MI Kaiser-Kupfer EA Bouzas A Pikus N Patronas 1994 Neurofibromatosis 2 (NF2): clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity Am J Med Genet 52 450 461 1:STN:280:DyaK2M3ms1KjtA%3D%3D 10.1002/ajmg.1320520411 7747758
4. VF Mautner M Lindenau ME Baser W Hazim M Tatagiba W Haase M Samii R Wais SM Pulst 1996 The neuroimaging and clinical spectrum of neurofibromatosis 2 Neurosurgery 38 880 885 1:STN:280:DyaK283ovVOnsw%3D%3D 10.1097/00006123- 199605000-00004 8727812 (Pubitemid 26125548)
5. A Drouet A Créange 2005 Polyneuropathy associated with neurofibromatosis Rev Neurol (Paris) 161 275 283 1:STN:280: DC%2BD2M7mvVOruw%3D%3D
6. ME McLaughlin SM Pepin M Maccollin P Choopong S Lessell 2007 Ocular pathologic findings of neurofibromatosis type 2 Arch Ophthalmol 125 389 394 10.1001/archopht.125.3.389 17353411 (Pubitemid 46425568)
7. MM Bosch E Boltshauser P Harpes K Landau 2006 Ophthalmologic findings and long-term course in patients with neurofibromatosis type 2 Am J Ophthalmol 141 1068 1077 10.1016/j.ajo.2005.12.042 16765675 (Pubitemid 43831029)
8. G Otsuka K Saito T Nagatani J Yoshida 2003 Age at symptom onset and long-term survival in patients with neurofibromatosis Type 2 J Neurosurg 99 480 483 10.3171/jns.2003.99.3.0480 12959433
9. J Antinheimo H Haapasalo M Haltia M Tatagiba S Thomas A Brandis M Sainio O Carpen M Samii J Jääskeläinen 1997 Proliferation potential and histological features in neurofibromatosis 2-associated and sporadic meningiomas J Neurosurg 87 610 614 1:STN:280:DyaK2svmt1KhsQ%3D%3D 10.3171/jns.1997.87.4. 0610 9322850
10. M Ruggieri P Iannetti A Polizzi IL Mantia A Spalice O Giliberto N Platania AL Gabriele V Albanese L Pavone 2005 Earliest clinical manifestations and natural history of neurofibromatosis type 2 (NF2) in childhood: a study of 24 patients Neuropediatrics 36 21 34 1:STN:280:DC%2BD2M7ktlKktA%3D%3D 10.1055/s-2005-837581 15776319 (Pubitemid 41115326)
11. A Perry C Giannini R Raghavan BW Scheithauer R Banerjee L Margraf DC Bowers RA Lytle IF Newsham DH Gutmann 2001 Aggressive phenotypic and genotypic features in pediatric and NF2-associated meningiomas: a clinicopathologic study of 53 cases J Neuropathol Exp Neurol 60 994 1003 1:STN:280: DC%2BD3Mrkt1Gntw%3D%3D 11589430
12. IM Germano MS Edwards RL Davis D Schiffer 1994 Intracranial meningiomas of the first two decades of life J Neurosurg 80 447 453 1:STN:280: DyaK2c7lslKgsg%3D%3D 10.3171/jns.1994.80.3.0447 8113857
13. DG Evans JM Birch RT Ramsden 1999 Paediatric presentation of type 2 neurofibromatosis Arch Dis Child 81 496 499 1:STN:280:DC%2BD3c%2FjvFymsA%3D%3D 10.1136/adc.81.6.496 10569966
14. P Rochat HH Johannesen F Gjerris 2004 Long-term follow up of children with meningiomas in Denmark: 1935 to 1984 J Neurosurg 100 179 182 14758946
15. EJ Rushing C Olsen H Mena M-E Rueda Y-S Lee RF Keating RJ Packer M Santi 2005 Central nervous system meningiomas in the first two decades of life: a clinicopathological analysis of 87 patients J Neurosurg 103 489 495 16383246
16. ME Baser JM Friedman D Aeschliman H Joe AJ Wallace RT Ramsden DGR Evans 2002 Predictors of the risk of mortality in neurofibromatosis 2 Am J Hum Genet 71 715 723 10.1086/342716 12235555
17. J Antinheimo R Sankila O Carpén E Pukkala M Sainio J Jääskeläinen 2000 Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and schwannomas Neurology 54 71 76 1:STN:280:DC%2BD3c7gtVSrsQ%3D%3D 10636128
18. L Kluwe V Mautner B Heinrich R Dezube LB Jacoby RE Friedrich M MacCollin 2003 Molecular study of frequency of mosaicism in neurofibromatosis 2 patients with bilateral vestibular schwannomas J Med Genet 40 109 114 1:CAS:528:DC%2BD3sXhslOgsL0%3D 10.1136/jmg.40.2.109 12566519
19. A Moyhuddin ME Baser C Watson S Purcell RT Ramsden A Heiberg AJ Wallace DGR Evans 2003 Somatic mosaicism in neurofibromatosis 2: prevalence and risk of disease transmission to offspring J Med Genet 40 459 463 1:STN:280: DC%2BD3s3otFSltg%3D%3D 10.1136/jmg.40.6.459 12807969
20. DG Evans AJ Wallace CL Wu L Trueman RT Ramsden T Strachan 1998 Somatic mosaicism: a common cause of classic disease in tumor-prone syndromes? Lessons from type 2 neurofibromatosis Am J Hum Genet 63 727 736 1:CAS:528: DyaK1cXmt1Gqu78%3D 9718334
21. DGR Evans C Watson A King AJ Wallace ME Baser 2005 Multiple meningiomas: differential involvement of the NF2 gene in children and adults J Med Genet 42 45 48 1:CAS:528:DC%2BD2MXht1Klt7Y%3D 10.1136/jmg.2004.023705 15635074 (Pubitemid 40187120)
22. JJ Larson JM Tew M Simon AG Menon 1995 Evidence for clonal spread in the development of multiple meningiomas J Neurosurg 83 705 709 1:STN:280: DyaK2MvgsVeisA%3D%3D 10.3171/jns.1995.83.4.0705 7674021
23. SM Pulst GA Rouleau C Marineau P Fain JP Sieb 1993 Familial meningioma is not allelic to neurofibromatosis 2 Neurology 43 2096 2098 1:STN:280: DyaK2c%2FitVantg%3D%3D 8413972
24. M Maxwell SD Shih T Galanopoulos ET Hedley-Whyte GR Cosgrove 1998 Familial meningioma: analysis of expression of neurofibromatosis 2 protein Merlin Report of two cases J Neurosurg 88 562 569 1:CAS:528:DyaK1cXhslGitLo%3D 10.3171/jns.1998.88.3.0562 9488313
25. Y Shen F Nunes A Stemmer-Rachamimov M James G Mohapatra S Plotkin RA Betensky DA Engler J Roy V Ramesh JF Gusella 2009 Genomic profiling distinguishes familial multiple and sporadic multiple meningiomas BMC Med Genomics 2 42 10.1186/1755-8794-2-42 19589153
26. DW Parsons S Jones X Zhang JC-H Lin RJ Leary P Angenendt, et al. 2008 An integrated genomic analysis of human glioblastoma multiforme Science 321 1807 1812 1:CAS:528:DC%2BD1cXhtFCrtLrE 10.1126/science.1164382 18772396
27. WH Slattery MH Lev LM Fisher SS Connell Z Iqbal JL Go 2005 NF2 Natural History Consortium MRI evaluation of neurofibromatosis 2 patients: a standardized approach for accuracy in interpretation Otol Neurotol 26 733 740 10.1097/01.mao.0000169048.15889.80 16015177 (Pubitemid 41026105)
28. A Mohyuddin WJ Neary A Wallace CL Wu S Purcell H Reid R Ramsden A Read G Black DGR Evans 2002 Molecular genetic analysis of the NF2 gene in young patients with unilateral vestibular schwannomas J Med Genet 39 315 322 1:CAS:528:DC%2BD38Xks1yju7Y%3D 10.1136/jmg.39.5.315 12011146
29. DGR Evans RT Ramsden C Gokhale N Bowers SM Huson A Wallace 2007 Should NF2 mutation screening be undertaken in patients with an apparently isolated vestibular schwannoma? Clin Genet 71 354 358 1:STN:280:DC%2BD2szhs1amtw%3D%3D 10.1111/j.1399-0004.2007.00778.x 17470137 (Pubitemid 46680801)
30. JM McGaughran DI Harris D Donnai D Teare R MacLeod R Westerbeek H Kingston M Super R Harris DG Evans 1999 A clinical study of type 1 neurofibromatosis in north west England J Med Genet 36 197 203 1:STN:280:DyaK1M3hvFGgug%3D%3D 10204844
31. A Créange J Zeller S Rostaing-Rigattieri P Brugières JD Degos J Revuz P Wolkenstein 1999 Neurological complications of neurofibromatosis type 1 in adulthood Brain 122 473 481 10.1093/brain/122.3.473 10094256 (Pubitemid 29110522)
32. M MacCollin W Woodfin D Kronn MP Short 1996 Schwannomatosis: a clinical and pathologic study Neurology 46 1072 1079 1:STN:280:DyaK28zntlyjsQ%3D%3D 8780094
33. M MacCollin EA Chiocca DG Evans JM Friedman R Horvitz D Jaramillo M Lev VF Mautner M Niimura SR Plotkin CN Sang A Stemmer-Rachamimov ES Roach 2005 Diagnostic criteria for schwannomatosis Neurology 64 1838 1845 1:STN:280:DC%2BD2MzgvFWmtg%3D%3D 10.1212/01.WNL.0000163982.78900.AD 15955931 (Pubitemid 40800695)
34. Hadfield KD, Smith MJ, Trump D, Newman WG, Evans DG (2010) SMARCB1 mutations are not a common cause of multiple meningiomas. J Med Genet. doi: 10.1136/jmg.2009.075721
35. C Boyd MJ Smith L Kluwe A Balogh M Maccollin SR Plotkin 2008 Alterations in the SMARCB1 (INI1) tumor suppressor gene in familial schwannomatosis Clin Genet 74 358 366 1:CAS:528:DC%2BD1cXhsVyms7zI 10.1111/j.1399-0004.2008.01060.x 18647326
36. TJM Hulsebos AS Plomp RA Wolterman EC Robanus-Maandag F Baas P Wesseling 2007 Germline mutation of INI1/SMARCB1 in familial schwannomatosis Am J Hum Genet 80 805 810 1:CAS:528:DC%2BD2sXktVOis7k%3D 10.1086/513207 17357086 (Pubitemid 46564417)
37. C Bacci R Sestini A Provenzano I Paganini I Mancini B Porfirio R Vivarelli M Genuardi L Papi 2010 Schwannomatosis associated with multiple meningiomas due to a familial SMARCB1 mutation Neurogenetics 11 73 80 1:CAS:528:DC%2BC3cXnt12itQ%3D%3D 10.1007/s10048-009-0204-2 19582488
38. Perry A, Kurtkaya-Yapicier O, Scheithauer BW, Robinson S, Prayson RA, Kleinschmidt-DeMasters BK, Stemmer-Rachamimov AO, Gutmann DH (2005) Insights into meningioangiomatosis with and without meningioma: a clinicopathologic and genetic series of 24 cases with review of the literature. Brain Pathol 15:55-65
39. IA Cunliffe DA Moffat DG Hardy AT Moore 1992 Bilateral optic nerve sheath meningiomas in a patient with neurofibromatosis type 2 Br J Ophthalmol 76 310 312 1:STN:280:DyaK3s%2Fgt1yntg%3D%3D 10.1136/bjo.76.5.310 1390517
40. H Kolles I Niedermayer C Schmitt W Henn R Feld WI Steudel KD Zang W Feiden 1995 Triple approach for diagnosis and grading of meningiomas: histology morphometry of Ki-67/Feulgen stainings and cytogenetics Acta Neurochir (Wien) 137 174 181 1:STN:280:DyaK28zotFKntw%3D%3D 10.1007/BF02187190 (Pubitemid 26002584)
41. R Wellenreuther JA Kraus D Lenartz AG Menon J Schramm DN Louis V Ramesh JF Gusella OD Wiestler A von Deimling 1995 Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma Am J Pathol 146 827 832 1:STN:280:DyaK2M3jtlCqsw%3D%3D 7717450
42. J Kros K de Greve A van Tilborg W Hop H Pieterman C Avezaat RLD Deprez E Zwarthoff 2001 NF2 status of meningiomas is associated with tumour localization and histology J Pathol 194 367 372 1:STN:280:DC%2BD3MzosFenug%3D%3D 10.1002/path.909 11439370 (Pubitemid 32624564)
43. K Lamszus F Vahldiek VF Mautner C Schichor J Tonn DF Stavrou, et al. 2000 Allelic losses in neurofibromatosis 2-associated meningiomas J Neuropathol Exp Neurol 59 504 512 1:CAS:528:DC%2BD3cXktlWrtbg%3D 10850863
44. D Mathieu D Kondziolka JC Flickinger A Niranjan R Williamson JJ Martin LD Lunsford 2007 Stereotactic radiosurgery for vestibular schwannomas in patients with neurofibromatosis type 2: an analysis of tumor control complications and hearing preservation rates Neurosurgery 60 460 470 17327790
45. D Kondziolka R Madhok LD Lunsford D Mathieu JJ Martin A Niranjan JC Flickinger 2009 Stereotactic radiosurgery for convexity meningiomas J Neurosurg 111 458 463 10.3171/2008.8.JNS17650 19199473
46. S Wentworth M Pinn JD Bourland AF Deguzman K Ekstrand TL Ellis SS Glazier KP McMullen M Munley VW Stieber SB Tatter EG Shaw 2009 Clinical experience with radiation therapy in the management of neurofibromatosis-associated central nervous system tumors Int J Radiat Oncol Biol Phys 73 208 213 18687535
47. DGR Evans JM Birch RT Ramsden S Sharif ME Baser 2006 Malignant transformation and new primary tumours after therapeutic radiation for benign disease: substantial risks in certain tumour prone syndromes J Med Genet 43 289 294 1:STN:280:DC%2BD287pvVKitA%3D%3D 10.1136/jmg.2005.036319 16155191
48. SR Plotkin AO Stemmer-Rachamimov FG Barker C Halpin TP Padera A Tyrrell AG Sorensen RK Jain E di Tomaso 2009 Hearing improvement after bevacizumab in patients with neurofibromatosis type 2 N Engl J Med 361 358 367 1:CAS:528:DC%2BD1MXovFCrsLY%3D 10.1056/NEJMoa0902579 19587327
49. DG Evans M Kalamarides K Hunter-Schaedle J Blakeley J Allen D Babovic-Vuskanovic, et al. 2009 Consensus recommendations to accelerate clinical trials for neurofibromatosis type 2 Clin Cancer Res 15 5032 5039 10.1158/1078-0432.CCR-08-3011 19671848
50. M Kalamarides M Niwa-Kawakita H Leblois V Abramowski M Perricaudet A Janin G Thomas DH Gutmann M Giovannini 2002 Nf2 gene inactivation in arachnoidal cells is rate-limiting for meningioma development in the mouse Genes Dev 16 1060 1065 1:CAS:528:DC%2BD38XjvV2ku74%3D 10.1101/gad.226302 12000789 (Pubitemid 34507195)
51. M Kalamarides AO Stemmer-Rachamimov M Takahashi ZY Han F Chareyre M Niwa-Kawakita PM Black RS Carroll M Giovannini 2008 Natural history of meningioma development in mice reveals: a synergy of Nf2 and p16(Ink4a) mutations Brain Pathol 18 62 70 10.1111/j.1750-3639.2007.00105.x 17924978